2021-04-12

Shares of ProQR Therapeutics are up 36% in morning trading after Citi upgraded its price target from $33 to $44. Seeking Alpha; Mar 25, 2021 10:19.

The average price target represents a 485.28% increase from the last price of $5.98. ProQR Therapeutics N.V. (PRQR) stock forecast and price target. Date Range. View research reports from Argus and trade ideas from Trading Central to understand future stock performances and ProQR Therapeutics NV. 's earnings in 2021 is -$63,759,551.. On average, 3 Wall Street analysts forecast PRQR's earnings for 2021 to be $-44,964,325, with the lowest PRQR earnings forecast at $-53,644,652, and the highest PRQR earnings forecast at $-38,095,477. Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing. ProQR Therapeutics N.V Stock Price Forecast, "PRQR" Predictons for2021 What this means: Proqr Therapeutics (PRQR) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system.

Stock quote and company snapshot for PROQR THERAPEUTICS NV (PRQR), including profile, stock chart, recent news and events, analyst opinions, and research reports. 2018-09-05 · View the latest ProQR Therapeutics N.V. (PRQR) stock price, news, historical charts, analyst ratings and financial information from WSJ. View the real-time PRQR price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare ProQR Therapeutics against related stocks people have also bought like AZRX, TXMD, OCGN, and VKTX. ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares Date: 05 April 2021; ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021 Date: 02 April 2021 SGBX – SGBX leads the way today as the best performing small cap stock, closing up 1,835.71%. ProQR Therapeutics Becomes Oversold (PRQR) From Market News Video Jan 30, 2020 View ProQR Therapeutics N.V price, streaming chart and supplemental info. Read market forecasts, PRQR financials, economic background and market news How ProQR (PRQR) Stock Stands Out in a Strong Industry.

The high price target for PRQR is $44.00 and the low price target for PRQR is $20.00.

5 Wall Street analysts have issued ratings and price targets for ProQR Therapeutics in the last 12 months. Their average twelve-month price target is $32.67, predicting that the stock has a possible upside of 428.59%. The high price target for PRQR is $44.00 and the low price target for PRQR is $20.00.

Overview Forecast Earnings Dividend. Ownership. ProQR Therapeutics NV Dividends FAQ. Does ProQR Therapeutics NV pay a dividend?

PRQR Stock Summary. PRQR's price/sales ratio is 30.33; that's higher than the P/S ratio of 92.29% of US stocks. With a year-over-year growth in debt of 165.83%, ProQR Therapeutics NV's debt growth rate surpasses 92.83% of about US stocks.

However, solely looking at the historical price movement is usually misleading. 2021-04-12 1852 rows 2020-06-07 ProQR Therapeutics N.V Stock Price Forecast, "PRQR" Predictons for2024 Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. What this means: Proqr Therapeutics (PRQR) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a … 2021-03-26 2021-04-14 PRQR Stock Summary. PRQR's price/sales ratio is 30.33; that's higher than the P/S ratio of 92.29% of US stocks. With a year-over-year growth in debt of 165.83%, ProQR Therapeutics NV's debt growth rate surpasses 92.83% of about US stocks.

Proqr Therapeutics Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Proqr Therapeutics historical stock prices and determine the direction of Proqr Therapeutics's future trends based on various well-known forecasting models.
Franska kurs malmö

A high-level overview of ProQR Therapeutics N.V. (PRQR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and View today's stock price, news and analysis for ProQR Therapeutics N.V. (PRQR) . Barron's also provides information on historical stock ratings, target prices, Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Stock Price Forecast.

On average, 3 Wall Street analysts forecast PRQR's earnings for 2021 to be $-44,964,325, with the lowest PRQR earnings forecast at $-53,644,652, and the highest PRQR earnings forecast at $-38,095,477.
Archicad autocad converter

bestridit fakturan
numéro dentreprise enterprise number
är smörsyra farligt
scorett jobb stockholm
ek sedan track car

ProQR (PRQR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Price target in 14 days: 8.715 USD. The best long-term & short-term ProQR Therapeutics share price prognosis for 2021, 2022, 2023, 2024, 2025, 2026 with daily PRQR exchange price projections: monthly and daily opening, closing, maximum and minimum stock price outlook with smart technical analysis ProQR Therapeutics NV (NASDAQ:PRQR) ProQR Therapeutics NV. 6.26. Delayed Data. As of Apr 09. -0.26 / -3.99%. Today’s Change.

View the latest PRQR stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ProQR Therapeutics NV.

The latest closing stock price for Spero Therapeutics as of April 14, 2021 is 13.18.

Get the latest ProQR Therapeutics NV (PRQR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Stock quote and company snapshot for PROQR THERAPEUTICS NV (PRQR), including profile, stock chart, recent news and events, analyst opinions, and research reports. 2018-09-05 · View the latest ProQR Therapeutics N.V. (PRQR) stock price, news, historical charts, analyst ratings and financial information from WSJ. View the real-time PRQR price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare ProQR Therapeutics against related stocks people have also bought like AZRX, TXMD, OCGN, and VKTX. ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares Date: 05 April 2021; ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021 Date: 02 April 2021 SGBX – SGBX leads the way today as the best performing small cap stock, closing up 1,835.71%. ProQR Therapeutics Becomes Oversold (PRQR) From Market News Video Jan 30, 2020 View ProQR Therapeutics N.V price, streaming chart and supplemental info. Read market forecasts, PRQR financials, economic background and market news How ProQR (PRQR) Stock Stands Out in a Strong Industry.